Fosrenol
lanthanum carbonate
- Strength
- 500 mg/1
- Form
- Tablet, Chewable
- Class
- Phosphate Binder
Takeda Pharmaceuticals America, Inc.
Not stocked by us — reference only
Listed by Ascend Laboratories, LLC
| Dosage form | Tablet, Chewable |
|---|---|
| Route | Oral |
| Drug class | Phosphate Binder |
| Approval route | ANDA — approved generic |
| NDC code | 67877-258 |
| FDA application | ANDA202329 |
| RxNorm concept | 477347 |
| Package sizes listed | 1 |
| Marketed since | May 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
lanthanum carbonate
Takeda Pharmaceuticals America, Inc.
Not stocked by us — reference only
lanthanum carbonate
Takeda Pharmaceuticals America, Inc.
Not stocked by us — reference only
lanthanum carbonate
Takeda Pharmaceuticals America, Inc.
Not stocked by us — reference only
lanthanum carbonate
Takeda Pharmaceuticals America, Inc.
Not stocked by us — reference only
lanthanum carbonate
Takeda Pharmaceuticals America, Inc.
Not stocked by us — reference only
Exelan Pharmaceuticals, Inc.
Not stocked by us — reference only
Lupin Pharmaceuticals, Inc.
Not stocked by us — reference only
Teva Pharmaceuticals USA, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.